ABVX.PA Net Margin

The Net Margin of Abivax SA (ABVX.PA) is -50800.00%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

ABVX.PA Net Margin - Historical Value

Date	Value
2024-12-31	-50800.00%

ABVX.PA Net Margin - Peers Comparison

Ticker	Name	Value
NANOV.OL	Nordic Nanovector ASA	-97289.40%
BVXP.L	Bioventix PLC	59.51%
SIGHT.PA	Gensight Biologics SA	-933.40%
DBV.PA	Dbv Technologies SA	-2749.29%
IPH.PA	Innate Pharma SA	-391.94%
MAB.WA	Mabion SA	-9.18%
ORY.MC	Oryzon Genomics SA	-26000.00%
SNG.L	Synairgen PLC	-3143.81%
TILS.L	Tiziana Life Sciences PLC	-589.47%
VLA.PA	Valneva SE	-7.22%
ALCLS.PA	Cellectis SA	-74.69%
BINV.ST	BioInvent International AB	-960.87%
FARN.L	Faron Pharmaceuticals Oy	-105715.80%
KDS.AS	Kiadis Pharma NV	-468.23%
NANO.PA	Nanobiotix SA	586.89%
OSE.PA	OSE Immunotherapeutics SA	44.88%
ALNOV.PA	Novacyt SA	-212.73%
BGBIO.OL	Bergenbio ASA	-16424.76%
SCLP.L	Scancell Holdings PLC	-226.57%
VVY.AS	Vivoryon Therapeutics NV	-117.57%
XBRANE.ST	Xbrane Biopharma AB	-133.97%
ALQGC.PA	Quantum Genomics SA	-31520.38%
SANION.ST	Saniona AB	56.39%
DMYD B.ST	Diamyd Medical AB	-116807.69%
IVA.PA	Inventiva SA	-2002.75%
POXEL.PA	Poxel SA	-1771.33%
TNG.PA	Transgene SA	-292.48%
XSPRAY.ST	XSpray Pharma AB (publ)	-8338.63%
HPHA.DE	Heidelberg Pharma AG	-282.98%
IVACC.ST	Intervacc AB	-640.66%
ORPHA.CO	Orphazyme A/S	-1731.11%